Felix Huth

10PUBLICATIONS
47CO-AUTHORS
Regenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsLiquid biopsiesMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 27, 2026
PBPK Modeling and Clinical Data Reveal Reduced Impact of CYP3A4 and CYP2C9 Inhibitors on Elimination of Siponimod.

|Mar 28, 2026
Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer.

Yan Ji, Felix Huth, Craig Wang

|Mar 20, 2026
Advances in Human Mass Balance Studies: An IQ Consortium Perspective on Current Practices and Emerging Trends.

Jason Boer, Ellen Cannady, Filip Cuyckens

|Mar 18, 2026
Pharmacokinetics of Asciminib 200 mg in the Presence of a Strong CYP3A4 Inducer, Phenytoin, in Healthy Participants.

Matthias Hoch, Amanda J Taylor, Felix Huth

|Dec 17, 2025
Guided Sample Pooling in Human Mass Balance Studies: A Recommended Strategic Decision Framework.

Filip Cuyckens, Wenying Li, Adam M Auclair

|Oct 29, 2024
Clinical Pharmacology of Asciminib: A Review.

Matthias Hoch, Felix Huth, Paul William Manley

Pageof 2

Frequent Collaborators

2 joint publications

Cathy Cantalloube

2 joint publications

Gregory S Walker

2 joint publications

Jason Boer

2 joint publications

S Cyrus Khojasteh